Embryo Selection From Polygenic Risk Scores Enters Market as Clinical Value Remains Unproven

Press/Media

Period	22 Dec 2021

Media coverage

Title	Embryo Selection From Polygenic Risk Scores Enters Market as Clinical Value Remains Unproven
Media name/outlet	GenomeWeb
Country/Territory	United States
Date	22/12/21
URL	https://www.genomeweb.com/sequencing/embryo-selection-polygenic-risk-scores-enters-market-clinical-value-remains-unproven
Persons	Alexander Charney